✦ LIBER ✦

ITP in Patients With CLL: Practicing With Patrick F. Fogarty, MD

Book ID: 118628023
Publisher: Frontline Medical Communications, Inc.
Year: 2010
Tongue: English
Weight: 67 KB
Volume: 7
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70297-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ITP in Elderly Patients: Practicing With

ITP in Elderly Patients: Practicing With S. Gerald Sandler, MD

📂 Article 📅 2009 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 64 KB

ITP in Patients Infected With Hepatitis

ITP in Patients Infected With Hepatitis C Virus: Practicing With Howard Liebman, MD

📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 74 KB

P-202 MDS development risk in CLL patien

P-202 MDS development risk in CLL patients with prolonged cytopenia after fludarabine, cyclophosphamide and rituximab (FCR) régime

✍ Jonasova, A.; Obrtlikova, P.; Siskova, M.; Cmunt, E.; Berkova, A.; Karban, J.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 81 KB

17p13/TP53 deletion in B-CLL patients is

17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation

✍ Dijkstra, M K; van Lom, K; Tielemans, D; Elstrodt, F; Langerak, A W; van ‘t Veer 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Direct and complement dependent cytotoxi

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early–intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

✍ Clive S. Zent; Charla R. Secreto; Betsy R. LaPlant; Nancy D. Bone; Timothy G. Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 373 KB

The mechanism of cytotoxicity of alemtuzumab and rituximab in chronic lymphocytic leukemia (CLL) is not well understood. We obtained fresh CLL cells from early-intermediate stage high-risk patients just prior to treatment with alemtuzumab and rituximab to study mechanisms of action and resistance. A

B-CLL developing in a patient with PV is

B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB